Exciting update for North America customers

We are delighted to announce the launch of a brand-new branch office dedicated to serving the needs of RGCC Network doctors in North America.

Find out more
Download our app Order a test
News

2021 cancer research round-up

Scientists worldwide are doing incredible things to improve the diagnosis and treatment of all forms of cancer. New approaches such as targeted immunotherapies are opening up new avenues for cancer treatment that prove highly effective. At RGCC, we’ve pioneered the use of personalised genetic testing for cancer diagnosis, and others are listening with the NHS […]

Read more
News

CTCs accurate predictor of chemotherapy resistance

Liquid biopsy tests before and during chemotherapy can accurately detect whether patients with prostate cancer are resistant to treatment with anti-cancer drug docetaxel, scientists have found. By analysing a blood test for circulating tumour cells (CTCs), researchers were able to identify patients who are resistant to docetaxel treatments. Identifying patterns in the data can predict […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more